SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-06-03 21:52
Tx date 2021-06-03 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$185,600
+10,000 vol
$18.56 each 		65,844
Filed 2021-05-20 20:53
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$13,475
+3,500 vol
$3.85 each 		116,206
Filed 2021-05-20 20:50
Tx date 2021-05-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-13,475
-3,500 vol
$3.85 each 		55,844
Filed 2021-02-18 20:59
Tx date 2021-02-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$82,406
+30,864 vol
$2.67 each 		92,076
Filed 2021-02-18 20:58
Tx date 2021-02-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-30,864 vol 		0
Filed 2021-02-18 20:56
Tx date 2021-02-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$38,477
+10,288 vol
$3.74 each 		61,212
Filed 2021-02-18 20:54
Tx date 2021-02-18 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-10,288 vol 		30,864
Filed 2021-02-18 20:49
Tx date 2021-02-16 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$13,734
+5,144 vol
$2.67 each 		112,706
Filed 2021-02-18 20:47
Tx date 2021-02-16 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-13,734.48
-5,144 vol
$2.67 each 		59,344
Filed 2020-06-02 19:59
Tx date 2020-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$131,100
+10,000 vol
$13.11 each 		64,488
Filed 2019-09-19 15:07
Tx date 2019-09-16 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$141,600
+15,000 vol
$9.44 each 		54,488
Filed 2019-03-20
Tx date 2019-03-19 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-20,576 vol 		41,152
Filed 2019-03-20
Tx date 2019-03-19 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$76,954
+20,576 vol
$3.74 each 		50,924
Filed 2019-03-14
Tx date 2019-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-24,045 vol 		107,562
Filed 2019-03-14
Tx date 2019-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-24,045 vol
Filed 2019-03-14
Tx date 2019-03-11 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Sandra Hayden (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
+17,337 vol 		114,403
Filed 2018-06-05
Tx date 2018-06-04 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+15,000 vol
$6.20 each 		39,488
Filed 2018-03-01
Tx date 2018-02-22 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
47 - Acquisition or disposition by gift
-29,580 vol 		131,607
Filed 2018-03-01
Tx date 2018-02-22 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Sandra Hayden (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
+21,180 vol 		97,066
Filed 2017-08-14
Tx date 2017-08-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$41,247
+15,000 vol
$2.75 each 		161,187
Filed 2017-06-02
Tx date 2017-06-01 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$13,475
+3,500 vol
$3.85 each 		24,488
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-3,086 vol 		61,728
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$11,541
+3,086 vol
$3.74 each 		30,348
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$17,312
+4,629 vol
$3.74 each 		27,262
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$15,390
+4,115 vol
$3.74 each 		22,633
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$19,238
+5,144 vol
$3.74 each 		146,187
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$96,192
+25,720 vol
$3.74 each 		141,043
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$67,334
+18,004 vol
$3.74 each 		115,323
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-18,004 vol 		51,852
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-25,720 vol 		26,132
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
-5,144 vol 		20,988
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-4,115 vol 		69,443
Filed 2017-03-15
Tx date 2017-03-14 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options
-4,629 vol 		64,814
Filed 2016-06-03
Tx date 2016-06-02 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$25,830
+3,500 vol
$7.38 each 		69,856
Filed 2016-05-27
Tx date 2016-05-25 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Options
51 - Exercise of options 		$-30,780.20
-8,230 vol
$3.74 each 		73,558
Filed 2016-05-27
Tx date 2016-05-25 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Holder: Genworks Inc. (Indirect Ownership)
Common Shares
51 - Exercise of options 		$30,780
+8,230 vol
$3.74 each 		18,518
Filed 2015-05-07
Tx date 2015-05-04 		$XENE
Xenon Pharmaceuticals Inc. 		Hayden, Michael R.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,086 vol 		66,356